Clinical trials
Terminated Phase 1/2 trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 3 |
| 2008 | 5 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 7 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 6 |
| Tokyo University | 5 |
| Amgen | 3 |
| Bristol-Myers Squibb | 2 |
| Eli Lilly and Company | 2 |
| Novartis Pharmaceuticals | 2 |
| Otsuka Pharmaceutical Co., Ltd. | 2 |
| Takeda | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Astellas Pharma Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 7 |
| Recurrence | 5 |
| Breast Neoplasms | 3 |
| Colorectal Neoplasms | 3 |
| Lymphoma | 3 |
| Multiple Myeloma | 3 |
| Stomach Neoplasms | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Carcinoma, Ovarian Epithelial | 2 |
| Colonic Neoplasms | 2 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.